Anti-apoptotic activity of NFkB, mainly activated through BCR signaling, is an important factor in CLL etiology and several pieces of evidence indicate that TCL1 is involved in NFkB activation (Figure 2). The gene discussed is NFKB1; the disease is B-cell chronic lymphocytic leukemia.